# María C. Cid

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maria-c-cid/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,241 |
| Field | Vasculitis and related conditions |
| h-index | 79 |
| i10-index | 186 |
| Last Known Institution | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| OpenAlex ID | https://openalex.org/A5059764745 |
| ORCID iD | https://orcid.org/0000-0002-4730-0938 |
| Works | 386 |

## Researcher papers

- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of-2/)
- [Trial of Tocilizumab in Giant-Cell Arteritis](https://scholariq.org/papers/trial-of-tocilizumab-in-giant-cell-arteritis/)
- [EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis](https://scholariq.org/papers/eular-era-edta-recommendations-for-the-management-of-anca-associated-vasculitis/)
- [Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis](https://scholariq.org/papers/mepolizumab-or-placebo-for-eosinophilic-granulomatosis-with-polyangiitis/)
- [EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-anca-associated-vasculitis-2022/)
- [2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative](https://scholariq.org/papers/2012-provisional-classification-criteria-for-polymyalgia-rheumatica-a-european/)
- [A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis](https://scholariq.org/papers/a-multicenter-randomized-double-blind-placebo-controlled-trial-of-adjuvant/)
- [Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis](https://scholariq.org/papers/evidence-based-guideline-for-the-diagnosis-and-management-of-eosinophilic/)
- [Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status](https://scholariq.org/papers/genome-wide-association-study-of-eosinophilic-granulomatosis-with-polyangiitis/)
- [Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial](https://scholariq.org/papers/mycophenolate-mofetil-versus-cyclophosphamide-for-remission-induction-in-anca/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Cell Adhesion Molecules Research](https://scholariq.org/topics/cell-adhesion-molecules-research/)

## Researcher university

- [Consorci Institut D'Investigacions Biomediques August Pi I Sunyer](https://scholariq.org/institutions/consorci-institut-d-investigacions-biomediques-august-pi-i-sunyer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.